Quarterly report pursuant to Section 13 or 15(d)

Equity-based Compensation - Schedule of Share-Based Payment Arrangement, Option, Activity (Details)

v3.24.3
Equity-based Compensation - Schedule of Share-Based Payment Arrangement, Option, Activity (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Number of Options    
Beginning balance (in shares) 39,820 39,820
Granted (in shares) 0  
Exercised (in shares) 0  
Forfeited/Repurchased (in shares) 0  
Ending balance (in shares) 39,820 39,820
Number of options vested (in shares) 31,190  
Weighted Average Exercise Price    
Beginning balance (in dollars per share) $ 81.47  
Granted (in dollars per share) 0  
Exercised (in dollars per share) $ 0  
Forfeited/Repurchased (in dollars per share) 0  
Ending balance (in dollars per share) $ 81.47 $ 81.47
Weighted Average Exercise Price Vested (in dollars per share) $ 81.03  
Weighted Average Remaining Contractual Term (years) 7 years 3 months 21 days 8 years 21 days
Weighted Average Remaining Contractual Term, Vested 7 years 3 months 25 days  
Aggregate Intrinsic Value $ 0 $ 0
Aggregate Intrinsic Value, Vested $ 0